Merrimack Pharmaceuticals (MACK) Short Interest Ratio & Short Volume

$14.73
0.00 (0.00%)
(As of 04/23/2024 ET)

Merrimack Pharmaceuticals Short Interest Data

Current Short Volume
722,800 shares
Previous Short Volume
729,900 shares
Change Vs. Previous Month
-0.97%
Dollar Volume Sold Short
$10.68 million
Short Interest Ratio / Days to Cover
6.2
Last Record Date
March 31, 2024
Outstanding Shares
14,532,000 shares
Percentage of Shares Shorted
4.97%
Today's Trading Volume
79,779 shares
Average Trading Volume
111,205 shares
Today's Volume Vs. Average
72%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Merrimack Pharmaceuticals ?

Sign up to receive the latest short interest report for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MACK Short Interest Over Time

MACK Days to Cover Over Time

MACK Percentage of Float Shorted Over Time

Merrimack Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024722,800 shares $10.68 million -1.0%N/A6.2 $14.77
3/15/2024729,900 shares $10.76 million -5.7%N/A7 $14.74
2/29/2024774,100 shares $11.38 million -5.9%N/A8.4 $14.70
2/15/2024822,900 shares $12.10 million +7.9%N/A9.7 $14.70
1/31/2024763,000 shares $10.22 million +1.5%N/A16.8 $13.40
1/15/2024752,100 shares $9.91 million -3.8%N/A18.8 $13.17
12/31/2023781,400 shares $10.48 million -10.4%N/A20.1 $13.41
12/15/2023871,600 shares $11.54 million -3.6%N/A23.4 $13.24
11/30/2023904,300 shares $11.41 million -1.8%N/A26.4 $12.62
11/15/2023921,100 shares $11.76 million -0.5%N/A27 $12.77
10/31/2023926,100 shares $11.33 million -2.6%N/A27.2 $12.23
10/15/2023951,100 shares $11.67 million -3.5%N/A21.3 $12.27
9/30/2023985,100 shares $12.15 million -5.3%N/A19.1 $12.33
9/15/20231,040,000 shares $12.73 million -2.8%N/A10.5 $12.24
8/31/20231,070,000 shares $13.06 million -2.7%N/A10.2 $12.21
8/15/20231,100,000 shares $13.38 million +1.9%N/A10.2 $12.16
7/31/20231,080,000 shares $12.97 million +3.9%N/A9.4 $12.01
7/15/20231,040,000 shares $12.15 million +5.4%N/A9.5 $11.68
6/30/2023986,900 shares $12.14 million +38.3%N/A9.2 $12.30
6/15/2023713,500 shares $8.84 million +4.4%N/A7.4 $12.39
5/31/2023683,700 shares $8.56 million -5.1%N/A9.2 $12.52
5/15/2023720,200 shares $9.20 million -8.8%N/A9.5 $12.77
4/30/2023789,600 shares $9.80 million -12.7%6.0%9.8 $12.41
4/15/2023904,700 shares $11.62 million +6.7%6.9%9.9 $12.84
3/31/2023847,700 shares $10.42 million -5.2%6.5%7 $12.29
3/15/2023894,500 shares $10.33 million -4.7%6.9%6.2 $11.55
2/28/2023938,100 shares $10.77 million -2.7%7.7%6 $11.48
2/15/2023964,000 shares $11.24 million +3.6%7.4%5.9 $11.66
1/31/2023930,300 shares $10.78 million +11.1%7.1%1.2 $11.59
1/15/2023837,100 shares $10.13 million +4.1%6.4%1.1 $12.10
12/30/2022804,300 shares $9.22 million +60.9%7.2%1.1 $11.46
12/15/2022499,800 shares $5.77 million -23.1%4.5%0.7 $11.55
11/30/2022649,800 shares $7.74 million -23.1%5.8%1 $11.91
11/15/2022844,700 shares $10.39 million +226.0%7.5%1.3 $12.30
10/31/2022259,100 shares $976,807.00 +1.0%2.3%0.5 $3.77
10/15/2022256,600 shares $857,044.00 -0.8%2.3%7 $3.34
9/30/2022258,700 shares $970,125.00 +2.0%2.3%8 $3.75
9/15/2022253,700 shares $1.11 million -2.8%2.3%8.7 $4.38
8/31/2022261,000 shares $1.08 million +0.9%2.3%8.8 $4.15
8/15/2022258,800 shares $1.09 million -0.7%2.3%9.2 $4.22
Exposed: 10 CENT Crypto to Explode April 20th? (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

MACK Short Interest - Frequently Asked Questions

What is Merrimack Pharmaceuticals' current short interest?

Short interest is the volume of Merrimack Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 722,800 shares of MACK short. Learn More on Merrimack Pharmaceuticals' current short interest.

What is a good short interest ratio for Merrimack Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MACK shares currently have a short interest ratio of 6.0. Learn More on Merrimack Pharmaceuticals's short interest ratio.

Is Merrimack Pharmaceuticals' short interest increasing or decreasing?

Merrimack Pharmaceuticals saw a drop in short interest in March. As of March 31st, there was short interest totaling 722,800 shares, a drop of 1.0% from the previous total of 729,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Merrimack Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Merrimack Pharmaceuticals: Acrivon Therapeutics, Inc. (4.43%), Immutep Limited (1.43%), Theseus Pharmaceuticals, Inc. (2.63%), ProQR Therapeutics (0.50%), NGM Biopharmaceuticals, Inc. (4.52%), Kinnate Biopharma Inc. (2.01%), Assembly Biosciences, Inc. (1.17%), vTv Therapeutics Inc. (6.11%), BeyondSpring Inc. (9.99%), AVROBIO, Inc. (0.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Merrimack Pharmaceuticals stock?

Short selling MACK is an investing strategy that aims to generate trading profit from Merrimack Pharmaceuticals as its price is falling. MACK shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Merrimack Pharmaceuticals?

A short squeeze for Merrimack Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MACK, which in turn drives the price of the stock up even further.

How often is Merrimack Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MACK, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MACK) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners